Clinical Trial: A Study to Evaluate the Effects of Therapeutic and Supratherapeutic Doses of KRP-S124 Compared to Placebo With Moxifloxacin on QTc Interval in Healthy Participants

U.S., Nov. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07919314) titled 'A Study to Evaluate the Effects of Therapeutic and Supratherapeutic Doses of KRP-S124 Compared to Placebo With Moxifloxacin on QTc Interval in Healthy Participants' on Oct. 31.

Brief Summary: This study is being done to see how KRP-S124 affects the electrical activity of the heart (known as the QTc interval [QT interval corrected for heart rate]) in healthy volunteers. This helps researchers check the heart safety of the study drug.

Study Start Date: Oct. 14

Study Type: INTERVENTIONAL

Condition: Healthy Participants

Intervention: DRUG: KRP-S124 Low Dose

Orally.

OTHER: Placebo

Orally.

DRUG: Moxifloxacin

Orally.

DRUG: KRP-S...